gip/glp-1 tirzepatide Tirzepatide, a dual receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction GLP1-GIP receptor co-agonists: a promising

Furthermore, RIVO Health provides an insurance concierge service specifically designed to help patients maximize their insurance coverage, ensuring treatments remain affordable long-term

You shouldnt stop taking it unless your doctor instructs you to stop taking it

Injection site reactions represent another category of commonly observed side effects

Our guide on switching between GLP-1 medications provides the dosage equivalency information you need for an informed conversation with your provider

It is also commonly prescribed off-label (for non-FDA-approved use) to help with weight loss and weight management in people with obesity or who are overweight with weight-related medical conditions